Pfizer | PFE

Stock Price
27.83
Daily Change
0.58 2.13%
Monthly
4.70%
Yearly
-28.03%
Q2 Forecast
25.31
Peers Price Chg Day Year Date
AbbVie 163.92 1.93 1.19% 11.17% May/06
Abbott 105.82 -0.41 -0.39% -4.58% May/06
ALKERMES 23.93 -0.14 -0.58% -16.45% May/01
Amgen 311.08 31.58 11.30% 32.59% May/06
AstraZeneca 12,050.00 -106.00 -0.87% 1.69% May/03
Bayer 28.16 0.14 0.50% -51.71% May/06
Biogen 221.41 3.71 1.70% -29.57% May/06
Bristol-Myers Squibb 43.93 0.02 0.05% -35.78% May/06
Catalent 56.37 0.03 0.06% 14.50% May/06
Gilead Sciences 65.36 -0.78 -1.19% -16.83% May/06
GlaxoSmithKline 1,733.50 5.00 0.29% 18.23% May/03
Glaxosmithkline 43.50 0.15 0.35% 18.30% May/06
J&J 149.26 -2.24 -1.48% -8.04% May/06
Eli Lilly 766.00 -41.46 -5.34% 77.02% May/06
Medtronic 81.76 0.10 0.12% -9.35% May/06
Merck 127.56 -1.28 -0.99% 7.75% May/06
Neurocrine Biosciences 140.71 0.88 0.63% 46.82% May/03
Novartis 88.51 0.54 0.61% -5.55% May/06
Novartis 97.68 0.35 0.36% -6.89% May/06
Prestige Brands 70.00 -1.26 -1.77% 17.65% May/06
Pacira 27.22 -0.10 -0.37% -36.90% May/03
Pfizer 27.83 0.58 2.13% -28.03% May/06
Perrigo 33.44 0.67 2.03% -9.49% May/06
Drreddys Laboratories 75.21 0.43 0.58% 24.42% May/06
Regeneron Pharmaceuticals 956.20 51.62 5.71% 27.13% May/06
Roche Holding 218.90 1.60 0.74% -22.95% May/06
Sanofi 91.49 0.19 0.21% -8.75% May/06
Sanofi 49.34 0.28 0.56% -10.18% May/06
Vertex Pharmaceuticals 405.20 -0.60 -0.15% 17.76% May/06
Zoetis 167.16 8.44 5.32% -9.58% May/06

Indexes Price Day Year Date
US500 5178 63.59 1.26% 25.12% May/07

Pfizer traded at $27.83 this Monday May 6th, increasing $0.58 or 2.13 percent since the previous trading session. Looking back, over the last four weeks, Pfizer gained 4.70 percent. Over the last 12 months, its price fell by 28.03 percent. Looking ahead, we forecast Pfizer to be priced at 25.31 by the end of this quarter and at 24.34 in one year, according to Trading Economics global macro models projections and analysts expectations.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.